Article
Epigenetic and oncogenic regulation of SLC16A7 (MCT2) results in protein over-expression, impacting on signalling and cellular phenotypes in prostate cancer.
Oncotarget - 28 Aug 2015
Pertega-Gomes Nelma, Vizcaino Jose R, Felisbino Sergio, Warren Anne Y, Shaw Greg, Kay Jonathan, Whitaker Hayley, Lynch Andy G, Fryer Lee, Neal David E, Massie Charles E
Abstract excerpt
Monocarboxylate Transporter 2 (MCT2) is a major pyruvate transporter encoded by the SLC16A7 gene. Recent studies pointed to a consistent overexpression of MCT2 in prostate cancer (PCa) suggesting MCT2 as a putative biomarker and molecular target. Despite the importance of this observation the mechanisms involved in MCT2 regulation are unknown. Through an integrative analysis we have discovered that selective...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
